DOCSLIB.ORG

Mouse Zc3h12a Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Zc3h12a Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Zc3h12a Knockout Project (CRISPR/Cas9) Objective: To create a Zc3h12a knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Zc3h12a gene (NCBI Reference Sequence: NM_153159 ; Ensembl: ENSMUSG00000042677 ) is located on Mouse chromosome 4. 6 exons are identified, with the ATG start codon in exon 2 and the TAA stop codon in exon 6 (Transcript: ENSMUST00000036188). Exon 2~6 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a null allele exhibit splenomegaly, lymphadenopathy, hyperimmunoglobulinemia, increased auto-antibodies, and defective IL6 post-transcriptional regulation. Exon 2 starts from about 0.06% of the coding region. Exon 2~6 covers 100.0% of the coding region. The size of effective KO region: ~7765 bp. The KO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 6 Legends Exon of mouse Zc3h12a Knockout region Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of start codon is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of stop codon is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com Overview of the GC Content Distribution (up) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(20.1% 402) | C(27.65% 553) | T(23.65% 473) | G(28.6% 572) Note: The 2000 bp section upstream of start codon is analyzed to determine the GC content. Significant high GC-content regions are found. The gRNA site is selected outside of these high GC-content regions. Overview of the GC Content Distribution (down) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(25.4% 508) | C(26.2% 524) | T(22.2% 444) | G(26.2% 524) Note: The 2000 bp section downstream of stop codon is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 4 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr4 - 125127049 125129048 2000 browser details YourSeq 138 160 321 2000 90.4% chr4 - 32919286 32919440 155 browser details YourSeq 134 158 306 2000 95.4% chr2 - 17012252 17012764 513 browser details YourSeq 133 160 305 2000 97.3% chr13 + 76507611 76507756 146 browser details YourSeq 133 161 306 2000 95.9% chr1 + 175377972 175378118 147 browser details YourSeq 133 160 306 2000 96.6% chr1 + 79731574 79731722 149 browser details YourSeq 132 160 305 2000 95.3% chr12 - 12407380 12407525 146 browser details YourSeq 132 160 306 2000 95.9% chr1 + 153494406 153494553 148 browser details YourSeq 131 165 307 2000 95.1% chr10 - 40215345 40215486 142 browser details YourSeq 131 160 305 2000 95.3% chr1 - 54982469 54982616 148 browser details YourSeq 131 171 516 2000 95.3% chr14 + 121407756 121408360 605 browser details YourSeq 130 163 298 2000 97.1% chr8 - 27125044 27125178 135 browser details YourSeq 130 160 302 2000 96.5% chr1 - 53988875 53989018 144 browser details YourSeq 130 159 302 2000 95.9% chr7 + 19189104 19189254 151 browser details YourSeq 130 165 306 2000 95.0% chr5 + 138158422 138158562 141 browser details YourSeq 130 160 305 2000 94.6% chr1 + 82780561 82780706 146 browser details YourSeq 129 160 298 2000 96.5% chr18 - 66390827 66390965 139 browser details YourSeq 129 161 302 2000 95.8% chr13 - 45305151 45305293 143 browser details YourSeq 129 160 305 2000 95.2% chr7 + 67991079 67991224 146 browser details YourSeq 129 160 305 2000 93.1% chr4 + 59327024 59327167 144 Note: The 2000 bp section upstream of start codon is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN -------------------------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr4 - 125117282 125119281 2000 browser details YourSeq 173 576 857 2000 91.8% chr7 - 110144717 110145260 544 browser details YourSeq 167 657 860 2000 93.3% chr12 - 22179781 22180051 271 browser details YourSeq 165 657 862 2000 89.9% chr5 - 122678452 122678643 192 browser details YourSeq 165 650 847 2000 90.2% chr5 + 30064552 30064745 194 browser details YourSeq 164 652 844 2000 94.6% chr8 - 43148812 43149005 194 browser details YourSeq 164 559 858 2000 91.8% chr11 - 51927440 51927790 351 browser details YourSeq 162 657 857 2000 89.5% chr4 + 41076050 41076243 194 browser details YourSeq 161 657 852 2000 91.7% chr3 - 31140435 31140638 204 browser details YourSeq 161 657 862 2000 89.8% chr12 - 21853004 21853201 198 browser details YourSeq 161 659 906 2000 93.1% chr1 + 159190491 159191098 608 browser details YourSeq 160 657 860 2000 91.2% chr11 + 78252861 78253065 205 browser details YourSeq 159 650 838 2000 93.1% chr16 + 8624580 8733096 108517 browser details YourSeq 159 657 842 2000 93.6% chr1 + 131878713 131878992 280 browser details YourSeq 158 655 844 2000 92.0% chr13 - 100211733 100211926 194 browser details YourSeq 158 657 859 2000 92.6% chr5 + 65516322 65516553 232 browser details YourSeq 158 657 859 2000 89.1% chr16 + 90256120 90256313 194 browser details YourSeq 157 657 856 2000 93.0% chr2 - 5945113 5945315 203 browser details YourSeq 157 652 856 2000 89.1% chr18 + 24439141 24439340 200 browser details YourSeq 157 657 834 2000 94.4% chr15 + 13330380 13330561 182 Note: The 2000 bp section downstream of stop codon is BLAT searched against the genome. No significant similarity is found. Page 5 of 8 https://www.alphaknockout.com Gene and protein information: Zc3h12a zinc finger CCCH type containing 12A [ Mus musculus (house mouse) ] Gene ID: 230738, updated on 11-Sep-2019 Gene summary Official Symbol Zc3h12a provided by MGI Official Full Name zinc finger CCCH type containing 12A provided by MGI Primary source MGI:MGI:2385891 See related Ensembl:ENSMUSG00000042677 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as Reg1; MCPIP; Mcpip1; MCPIP-1; BC036563 Expression Broad expression in large intestine adult (RPKM 23.3), spleen adult (RPKM 14.6) and 15 other tissues See more Orthologs human all Genomic context Location: 4; 4 D2.2 See Zc3h12a in Genome Data Viewer Exon count: 6 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 4 NC_000070.6 (125118414..125127881, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 4 NC_000070.5 (124795658..124805125, complement) Chromosome 4 - NC_000070.6 Page 6 of 8 https://www.alphaknockout.com Transcript information: This gene has 2 transcripts Gene: Zc3h12a ENSMUSG00000042677 Description zinc finger CCCH type containing 12A [Source:MGI Symbol;Acc:MGI:2385891] Gene Synonyms Mcpip1 Location Chromosome 4: 125,118,423-125,127,840 reverse strand. GRCm38:CM000997.2 About this gene This gene has 2 transcripts (splice variants), 257 orthologues, 6 paralogues, is a member of 1 Ensembl protein family and is associated with 33 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Zc3h12a-201 ENSMUST00000036188.7 2755 596aa ENSMUSP00000037172.7 Protein coding CCDS18638 Q5D1E7 TSL:1 GENCODE basic APPRIS P1 Zc3h12a-202 ENSMUST00000131685.1 660 No protein - Retained intron - - TSL:1 29.42 kb Forward strand 125.11Mb 125.12Mb 125.13Mb Genes Meaf6-205 >protein coding (Comprehensive set... Meaf6-201 >protein coding Meaf6-208 >nonsense mediated decay Meaf6-202 >protein coding Meaf6-207 >nonsense mediated decay Meaf6-206 >retained intron Contigs AL626775.11 > Genes < Zc3h12a-201protein coding (Comprehensive set... < Zc3h12a-202retained intron Regulatory Build 125.11Mb 125.12Mb 125.13Mb Reverse strand 29.42 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding Ensembl protein coding merged Ensembl/Havana Non-Protein Coding processed transcript Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000036188 < Zc3h12a-201protein coding Reverse strand 9.42 kb ENSMUSP00000037... PDB-ENSP mappings MobiDB lite Low complexity (Seg) Pfam Rege-1, UBA-like domain Endoribonuclease Regnase 1/ZC3H12, C-terminal domain Ribonuclease Zc3h12a-like, NYN domain PANTHER PTHR12876:SF10 PTHR12876 Gene3D 3.40.50.11980 CDD cd18729 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 60 120 180 240 300 360 420 480 596 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 8 of 8.
Load more

Recommended publications
  • Binding Specificities of Human RNA Binding Proteins Towards Structured
    bioRxiv preprint doi: https://doi.org/10.1101/317909; this version posted March 1, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Binding specificities of human RNA binding proteins towards structured and linear 2 RNA sequences 3 4 Arttu Jolma1,#, Jilin Zhang1,#, Estefania Mondragón4,#, Teemu Kivioja2, Yimeng Yin1, 5 Fangjie Zhu1, Quaid Morris5,6,7,8, Timothy R. Hughes5,6, Louis James Maher III4 and Jussi 6 Taipale1,2,3,* 7 8 9 AUTHOR AFFILIATIONS 10 11 1Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden 12 2Genome-Scale Biology Program, University of Helsinki, Helsinki, Finland 13 3Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom 14 4Department of Biochemistry and Molecular Biology and Mayo Clinic Graduate School of 15 Biomedical Sciences, Mayo Clinic College of Medicine and Science, Rochester, USA 16 5Department of Molecular Genetics, University of Toronto, Toronto, Canada 17 6Donnelly Centre, University of Toronto, Toronto, Canada 18 7Edward S Rogers Sr Department of Electrical and Computer Engineering, University of 19 Toronto, Toronto, Canada 20 8Department of Computer Science, University of Toronto, Toronto, Canada 21 #Authors contributed equally 22 *Correspondence: [email protected] 23 24 25 SUMMARY 26 27 Sequence specific RNA-binding proteins (RBPs) control many important 28 processes affecting gene expression. They regulate RNA metabolism at multiple 29 levels, by affecting splicing of nascent transcripts, RNA folding, base modification, 30 transport, localization, translation and stability. Despite their central role in most 31 aspects of RNA metabolism and function, most RBP binding specificities remain 32 unknown or incompletely defined.
    [Show full text]
  • Analysis of the Indacaterol-Regulated Transcriptome in Human Airway
    Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2018/04/13/jpet.118.249292.DC1 1521-0103/366/1/220–236$35.00 https://doi.org/10.1124/jpet.118.249292 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 366:220–236, July 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the s Adverse and Therapeutic Effects of b2-Adrenoceptor Agonists Dong Yan, Omar Hamed, Taruna Joshi,1 Mahmoud M. Mostafa, Kyla C. Jamieson, Radhika Joshi, Robert Newton, and Mark A. Giembycz Departments of Physiology and Pharmacology (D.Y., O.H., T.J., K.C.J., R.J., M.A.G.) and Cell Biology and Anatomy (M.M.M., R.N.), Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Received March 22, 2018; accepted April 11, 2018 Downloaded from ABSTRACT The contribution of gene expression changes to the adverse and activity, and positive regulation of neutrophil chemotaxis. The therapeutic effects of b2-adrenoceptor agonists in asthma was general enriched GO term extracellular space was also associ- investigated using human airway epithelial cells as a therapeu- ated with indacaterol-induced genes, and many of those, in- tically relevant target. Operational model-fitting established that cluding CRISPLD2, DMBT1, GAS1, and SOCS3, have putative jpet.aspetjournals.org the long-acting b2-adrenoceptor agonists (LABA) indacaterol, anti-inflammatory, antibacterial, and/or antiviral activity. Numer- salmeterol, formoterol, and picumeterol were full agonists on ous indacaterol-regulated genes were also induced or repressed BEAS-2B cells transfected with a cAMP-response element in BEAS-2B cells and human primary bronchial epithelial cells by reporter but differed in efficacy (indacaterol $ formoterol .
    [Show full text]
  • The Roles of Malt1 in Nf-Κb Activation and Solid Tumor Progression
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 5-2016 THE ROLES OF MALT1 IN NF-κB ACTIVATION AND SOLID TUMOR PROGRESSION Deng Pan Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Animal Diseases Commons, Animals Commons, Biochemistry Commons, Cancer Biology Commons, Cell Biology Commons, Disease Modeling Commons, Molecular Biology Commons, Molecular Genetics Commons, and the Oncology Commons Recommended Citation Pan, Deng, "THE ROLES OF MALT1 IN NF-κB ACTIVATION AND SOLID TUMOR PROGRESSION" (2016). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 651. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/651 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. THE ROLES OF MALT1 IN NF-κB ACTIVATION AND SOLID TUMOR PROGRESSION by Deng Pan, B.S. APPROVED: ______________________________ Xin Lin, Ph.D. , Advisory Professor ______________________________ Paul Chiao, Ph.D. ______________________________ Dos Sarbassov, Ph.D. ______________________________ M. James You, M.D., Ph.D. ______________________________ Chengming Zhu, Ph.D.
    [Show full text]
  • Regnase-1, a Rapid Response Ribonuclease Regulating Inflammation and Stress Responses
    Cellular & Molecular Immunology (2017) 14, 412–422 & 2017 CSI and USTC All rights reserved 2042-0226/17 $32.00 www.nature.com/cmi REVIEW Regnase-1, a rapid response ribonuclease regulating inflammation and stress responses Renfang Mao1, Riyun Yang1, Xia Chen1, Edward W Harhaj2, Xiaoying Wang3 and Yihui Fan1,3 RNA-binding proteins (RBPs) are central players in post-transcriptional regulation and immune homeostasis. The ribonuclease and RBP Regnase-1 exerts critical roles in both immune cells and non-immune cells. Its expression is rapidly induced under diverse conditions including microbial infections, treatment with inflammatory cytokines and chemical or mechanical stimulation. Regnase-1 activation is transient and is subject to negative feedback mechanisms including proteasome-mediated degradation or mucosa-associated lymphoid tissue 1 (MALT1) mediated cleavage. The major function of Regnase-1 is promoting mRNA decay via its ribonuclease activity by specifically targeting a subset of genes in different cell types. In monocytes, Regnase-1 downregulates IL-6 and IL-12B mRNAs, thus mitigating inflammation, whereas in T cells, it restricts T-cell activation by targeting c-Rel, Ox40 and Il-2 transcripts. In cancer cells, Regnase-1 promotes apoptosis by inhibiting anti-apoptotic genes including Bcl2L1, Bcl2A1, RelB and Bcl3. Together with up-frameshift protein-1 (UPF1), Regnase-1 specifically cleaves mRNAs that are active during translation by recognizing a stem-loop (SL) structure within the 3′UTRs of these genes in endoplasmic reticulum-bound ribosomes. Through this mechanism, Regnase-1 rapidly shapes mRNA profiles and associated protein expression, restricts inflammation and maintains immune homeostasis. Dysregulation of Regnase-1 has been described in a multitude of pathological states including autoimmune diseases, cancer and cardiovascular diseases.
    [Show full text]
  • An Auto-Regulatory Module Controls Fat Metabolism in Caenorhabditis
    An auto-regulatory module controls fat metabolism in Caenorhabditis elegans Inauguraldissertation zur Erlangung der Würde einer Doktorin der Philosophie vorgelegt der Philosophisch-Naturwisschenschaftlichen Fakultät der Universität Basel von Cornelia Habacher aus Österreich Basel, 2018 Originaldokument gespeichert auf dem Dokumentenserver der Universität Basel edoc.unibas.ch Genemigt von der Philosophisch-Naturwissenschaftlichen Fakultät auf Antrag von: Prof. Dr. Michael Hall Dr. Rafal Ciosk Dr. Hugo Aguilaniu Basel, den 23. Mai 2017 Prof. Dr. Martin Spiess (Dekan der Philosophisch-Naturwissenschaftlichen Fakultät der Universität Basel) 2 TABLE OF CONTENTS SUMMARY .........................................................................................................................................4 1. INTRODUCTION ..............................................................................................................................5 1.1 Fat metabolism in Caenorhabditis elegans ......................................................................................... 5 1.1.1 Absorption of nutrients ................................................................................................................ 6 1.1.2 Lipid composition and fat accumulation ...................................................................................... 8 1.1.3 Lipid degradation ......................................................................................................................... 9 1.1.4 Signaling pathways regulating lipid
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • IL-17 Mrna Induced by Zc3h12a Stability of the CIKS/DDX3X
    CIKS/DDX3X Interaction Controls the Stability of the Zc3h12a mRNA Induced by IL-17 This information is current as Domenico Somma, Paola Mastrovito, Marianeve Grieco, of September 23, 2021. Alfonso Lavorgna, Angelica Pignalosa, Luigi Formisano, Anna Maria Salzano, Andrea Scaloni, Francesco Pacifico, Ulrich Siebenlist and Antonio Leonardi J Immunol 2015; 194:3286-3294; Prepublished online 20 February 2015; Downloaded from doi: 10.4049/jimmunol.1401589 http://www.jimmunol.org/content/194/7/3286 Supplementary http://www.jimmunol.org/content/suppl/2015/02/20/jimmunol.140158 http://www.jimmunol.org/ Material 9.DCSupplemental References This article cites 43 articles, 15 of which you can access for free at: http://www.jimmunol.org/content/194/7/3286.full#ref-list-1 Why The JI? Submit online. by guest on September 23, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association
    [Show full text]
  • MCPIP (H-6): Sc-515275
    SANTA CRUZ BIOTECHNOLOGY, INC. MCPIP (H-6): sc-515275 BACKGROUND RECOMMENDED SUPPORT REAGENTS MCPIP (MCP-induced protein 1), also known as ZC3H12A (zinc finger CCCH- To ensure optimal results, the following support reagents are recommended: type containing 12A), is a 599 amino acid protein that localizes to the nucleus 1) Western Blotting: use m-IgGk BP-HRP: sc-516102 or m-IgGk BP-HRP (Cruz and contains one C3H1-type zinc finger. Functioning as a transcriptional acti- Marker): sc-516102-CM (dilution range: 1:1000-1:10000), Cruz Marker™ vator, MCPIP triggers apoptosis and promotes MCP-1 and CJR-2B-induced Molecular Weight Standards: sc-2035, UltraCruz® Blocking Reagent: angiogenesis, possibly playing a role in the development of acute monocytic sc-516214 and Western Blotting Luminol Reagent: sc-2048. 2) Immunopre- leukemia. Overexpression of MCPIP is associated with ischemic heart dis- cipitation: use Protein L-Agarose: sc-2336 (0.5 ml agarose/2.0 ml). 3) Immu- ease, a condition characterized by reduced blood flow to the heart, often as nofluorescence: use m-IgGk BP-FITC: sc-516140 or m-IgGk BP-PE: sc-516141 a result of coronary artery disease. The gene encoding MCPIP maps to human (dilution range: 1:50-1:200) with UltraCruz® Mounting Medium: sc-24941 or chromosome 1, which spans 260 million base pairs, contains over 3,000 genes UltraCruz® Hard-set Mounting Medium: sc-359850. and comprises nearly 8% of the human genome. DATA CHROMOSOMAL LOCATION Genetic locus: ZC3H12A (human) mapping to 1p34.3; Zc3h12a (mouse) ABCDE F AB C mapping to 4 D2.2.
    [Show full text]
  • Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards
    Table S1. 103 ferroptosis-related genes retrieved from the GeneCards. Gene Symbol Description Category GPX4 Glutathione Peroxidase 4 Protein Coding AIFM2 Apoptosis Inducing Factor Mitochondria Associated 2 Protein Coding TP53 Tumor Protein P53 Protein Coding ACSL4 Acyl-CoA Synthetase Long Chain Family Member 4 Protein Coding SLC7A11 Solute Carrier Family 7 Member 11 Protein Coding VDAC2 Voltage Dependent Anion Channel 2 Protein Coding VDAC3 Voltage Dependent Anion Channel 3 Protein Coding ATG5 Autophagy Related 5 Protein Coding ATG7 Autophagy Related 7 Protein Coding NCOA4 Nuclear Receptor Coactivator 4 Protein Coding HMOX1 Heme Oxygenase 1 Protein Coding SLC3A2 Solute Carrier Family 3 Member 2 Protein Coding ALOX15 Arachidonate 15-Lipoxygenase Protein Coding BECN1 Beclin 1 Protein Coding PRKAA1 Protein Kinase AMP-Activated Catalytic Subunit Alpha 1 Protein Coding SAT1 Spermidine/Spermine N1-Acetyltransferase 1 Protein Coding NF2 Neurofibromin 2 Protein Coding YAP1 Yes1 Associated Transcriptional Regulator Protein Coding FTH1 Ferritin Heavy Chain 1 Protein Coding TF Transferrin Protein Coding TFRC Transferrin Receptor Protein Coding FTL Ferritin Light Chain Protein Coding CYBB Cytochrome B-245 Beta Chain Protein Coding GSS Glutathione Synthetase Protein Coding CP Ceruloplasmin Protein Coding PRNP Prion Protein Protein Coding SLC11A2 Solute Carrier Family 11 Member 2 Protein Coding SLC40A1 Solute Carrier Family 40 Member 1 Protein Coding STEAP3 STEAP3 Metalloreductase Protein Coding ACSL1 Acyl-CoA Synthetase Long Chain Family Member 1 Protein
    [Show full text]
  • Integrative Bioinformatic Analysis of Transcriptomic Data Identifies Conserved Molecular Pathways Underlying Ionizing Radiation-Induced Bystander Effects (RIBE)
    cancers Article Integrative Bioinformatic Analysis of Transcriptomic Data Identifies Conserved Molecular Pathways Underlying Ionizing Radiation-Induced Bystander Effects (RIBE) Constantinos Yeles 1,2, Efstathios-Iason Vlachavas 2,3,4, Olga Papadodima 2, Eleftherios Pilalis 4, Constantinos E. Vorgias 1, Alexandros G. Georgakilas 5 ID and Aristotelis Chatziioannou 2,4,* 1 Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Zografou Campus, 15701 Athens, Greece; [email protected] (C.Y.); [email protected] (C.E.V.) 2 Metabolic Engineering and Bioinformatics Research Team, Institute of Biology Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation, 11635 Athens, Greece; [email protected] (E.-I.V); [email protected] (O.P.) 3 Department of Molecular Biology and Genetics, Democritus University of Thrace, 68100 Dragana, Greece 4 Enios Applications Private Limited Company, A17671 Athens, Greece; [email protected] 5 Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Zografou, 15780 Athens, Greece; [email protected] * Correspondence: [email protected]; Tel.: +30-210-727-3751 Received: 6 November 2017; Accepted: 22 November 2017; Published: 25 November 2017 Abstract: Ionizing radiation-induced bystander effects (RIBE) encompass a number of effects with potential for a plethora of damages in adjacent non-irradiated tissue. The cascade of molecular events is initiated in response to the exposure to ionizing radiation (IR), something that may occur during diagnostic or therapeutic medical applications. In order to better investigate these complex response mechanisms, we employed a unified framework integrating statistical microarray analysis, signal normalization, and translational bioinformatics functional analysis techniques.
    [Show full text]
  • ZC3H12D Is a Prognostic Biomarker Associated with Immune Cell Infiltration in Lung Adenocarcinoma
    6142 Original Article ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma Wangang Gong1,2,3, Wumin Dai1,2,3, Haibin Wei1,2,3, Yongyi Chen1,2,3, Zhiguo Zheng1,2,3 1Institute of Cancer and Basic Medical (ICBM), Chinese Academy of Sciences, Hangzhou, China; 2Zhejiang Cancer Research Institute, Cancer Hospital of University of Chinese Academy of Sciences, Hangzhou, China; 3Zhejiang Cancer Research Institute, Zhejiang Cancer Hospital, Hangzhou, China Contributions: (I) Conception and design: Z Zheng; (II) Administrative support: Z Zheng; (III) Provision of study materials or patients: W Dai, Y Chen; (IV) Collection and assembly of data: W Gong, H Wei; (V) Data analysis and interpretation: W Gong; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Zhiguo Zheng, PhD. Zhejiang Cancer Research Institute, Zhejiang Cancer Hospital, 1# Banshan Road, Hangzhou 310022, China. Email: [email protected]. Background: ZC3H12 family members have an important role in tumorigenesis and development. However, the relationship between ZC3H12 family members and the prognosis of lung adenocarcinoma (LUAD) and tumor infiltrating lymphocytes is not clear. Methods: The expression of ZC3H12 family members in LUAD was analyzed by UALCAN. UALCAN, Kaplan–Meier Plotter, and GEPIA were used to evaluate the effect of ZC3H12 family members on the prognosis of LUAD. The relationship between prognostic ZC3H12 family members and 14 functional states of LUAD was studied by CancerSEA. The correlation between ZC3H12 and immune cell infiltration was studied by TIMMER. In addition, the correlation between ZC3H12D expression and an immune infiltration gene marker set was analyzed by TISIDB and GEPIA.
    [Show full text]
  • Data-Driven and Knowledge-Driven Computational Models of Angiogenesis in Application to Peripheral Arterial Disease
    DATA-DRIVEN AND KNOWLEDGE-DRIVEN COMPUTATIONAL MODELS OF ANGIOGENESIS IN APPLICATION TO PERIPHERAL ARTERIAL DISEASE by Liang-Hui Chu A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland March, 2015 © 2015 Liang-Hui Chu All Rights Reserved Abstract Angiogenesis, the formation of new blood vessels from pre-existing vessels, is involved in both physiological conditions (e.g. development, wound healing and exercise) and diseases (e.g. cancer, age-related macular degeneration, and ischemic diseases such as coronary artery disease and peripheral arterial disease). Peripheral arterial disease (PAD) affects approximately 8 to 12 million people in United States, especially those over the age of 50 and its prevalence is now comparable to that of coronary artery disease. To date, all clinical trials that includes stimulation of VEGF (vascular endothelial growth factor) and FGF (fibroblast growth factor) have failed. There is an unmet need to find novel genes and drug targets and predict potential therapeutics in PAD. We use the data-driven bioinformatic approach to identify angiogenesis-associated genes and predict new targets and repositioned drugs in PAD. We also formulate a mechanistic three- compartment model that includes the anti-angiogenic isoform VEGF165b. The thesis can serve as a framework for computational and experimental validations of novel drug targets and drugs in PAD. ii Acknowledgements I appreciate my advisor Dr. Aleksander S. Popel to guide my PhD studies for the five years at Johns Hopkins University. I also appreciate several professors on my thesis committee, Dr. Joel S. Bader, Dr.
    [Show full text]